CECT in Pulmonary Thrombolism

Shaha Pramod

Department of Radiology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.

Ragi Skanda *

Department of Radiology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.

Bhoite Amol

Department of Radiology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.

Tamboli Asif

Department of Radiology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.

Gautama Amol

Department of Radiology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.

*Author to whom correspondence should be addressed.


Abstract

Introduction: Pulmonary embolism (PE) is the third most common acute heart disease after myocardial infarction and stroke and is a major public health problem. PE is a disease that has high morbidity and mortality, yet it is challenging to obtain a diagnosis.

Objective: The study aims to assess the role of MDCT-PA in the diagnosis of pulmonary embolism, and it's associated conditions in suspected cases of pulmonary embolism.

Materials and Methods: The study was conducted in the department of radiology in KRISHNA INSTITUTE OF MEDICAL SCIENCES DEEMED TO BE UNIVERSITY situated in KARAD equipped with a 16 slice MDCT scanner (EMOTION) manufactured by Siemens.

Results: Through the study period of one and half year and have met the inclusion criteria, a total of 90 consecutive patients who presented with suspicion of PE were referred for MDCT-PA in the department of radio-diagnosis, Krishna Hospital, Karad. A review of all the cases was done, and the results were presented in the form of tables.

Conclusion: Multidetector computed tomography pulmonary angiography can be used to confidently diagnose pulmonary embolism in which it is not contraindicated. MDCT-PA is the investigation of choice because it is a rapid, non-invasive study, highly sensitive and specific.

Keywords: Pulmonary embolism, angiography, ultra-sonography, computed tomography


How to Cite

Pramod, S., Skanda, R., Amol, B., Asif, T. and Amol, G. (2021) “CECT in Pulmonary Thrombolism”, Journal of Pharmaceutical Research International, 33(53B), pp. 284–293. doi: 10.9734/jpri/2021/v33i53B33709.